Unplugging JAK/STAT in chronic myelomonocytic leukemia

Eric Solary

doi:10.1158/1078-0432.CCR-16-0372

Unplugging JAK/STAT in chronic myelomonocytic leukemia

Eric Solary

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

8 Citations (Scopus)

Résumé

The proliferative component of chronic myelomonocytic leukemia, related to an increased sensitivity of myeloid progenitors to granulocyte macrophage-colony stimulating factor, suggests dedicated therapeutic approaches.

langue originale	Anglais
Pages (de - à)	3707-3709
Nombre de pages	3
journal	Clinical Cancer Research
Volume	22
Numéro de publication	15
Les DOIs	https://doi.org/10.1158/1078-0432.CCR-16-0372
état	Publié - 1 août 2016

Accès au document

10.1158/1078-0432.CCR-16-0372

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{69a75ea5c0264869bc8fa149dde9cb0e,

title = "Unplugging JAK/STAT in chronic myelomonocytic leukemia",

abstract = "The proliferative component of chronic myelomonocytic leukemia, related to an increased sensitivity of myeloid progenitors to granulocyte macrophage-colony stimulating factor, suggests dedicated therapeutic approaches.",

author = "Eric Solary",

note = "Publisher Copyright: {\textcopyright}2016 AACR.",

year = "2016",

month = aug,

day = "1",

doi = "10.1158/1078-0432.CCR-16-0372",

language = "English",

volume = "22",

pages = "3707--3709",

journal = "Clinical Cancer Research",

issn = "1078-0432",

number = "15",

}

TY - JOUR

T1 - Unplugging JAK/STAT in chronic myelomonocytic leukemia

AU - Solary, Eric

PY - 2016/8/1

Y1 - 2016/8/1

N2 - The proliferative component of chronic myelomonocytic leukemia, related to an increased sensitivity of myeloid progenitors to granulocyte macrophage-colony stimulating factor, suggests dedicated therapeutic approaches.

AB - The proliferative component of chronic myelomonocytic leukemia, related to an increased sensitivity of myeloid progenitors to granulocyte macrophage-colony stimulating factor, suggests dedicated therapeutic approaches.

UR - http://www.scopus.com/inward/record.url?scp=84980347753&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-16-0372

DO - 10.1158/1078-0432.CCR-16-0372

M3 - Article

C2 - 26979390

AN - SCOPUS:84980347753

SN - 1078-0432

VL - 22

SP - 3707

EP - 3709

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 15

ER -